HEADER IMMUNE SYSTEM 21-JUL-09 3IDJ TITLE CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY TITLE 2 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2F5 FAB LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: 2F5 FAB HEAVY CHAIN; COMPND 6 CHAIN: B; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: GP41 MPER PEPTIDE ANALOG; COMPND 9 CHAIN: C; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_TAXID: 9606; SOURCE 7 MOL_ID: 3; SOURCE 8 SYNTHETIC: YES KEYWDS HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.-P.JULIEN,S.BRYSON,E.F.PAI REVDAT 2 01-NOV-17 3IDJ 1 REMARK REVDAT 1 02-FEB-10 3IDJ 0 JRNL AUTH S.BRYSON,J.P.JULIEN,R.C.HYNES,E.F.PAI JRNL TITL CRYSTALLOGRAPHIC DEFINITION OF THE EPITOPE PROMISCUITY OF JRNL TITL 2 THE BROADLY NEUTRALIZING ANTI-HUMAN IMMUNODEFICIENCY VIRUS JRNL TITL 3 TYPE 1 ANTIBODY 2F5: VACCINE DESIGN IMPLICATIONS. JRNL REF J.VIROL. V. 83 11862 2009 JRNL REFN ISSN 0022-538X JRNL PMID 19740978 JRNL DOI 10.1128/JVI.01604-09 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1713872.210 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 30413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1503 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.24 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4781 REMARK 3 BIN R VALUE (WORKING SET) : 0.3120 REMARK 3 BIN FREE R VALUE : 0.3100 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 260 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3418 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : 0.32000 REMARK 3 B33 (A**2) : -0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.130 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 35.41 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_ORN.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IDJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1000054276. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : XENOCS OPTICS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30413 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 80.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04500 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.18100 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE, PH 5.6, 1.4 M REMARK 280 AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.20000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.80000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.45000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.80000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.20000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.45000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 128 REMARK 465 LYS B 129 REMARK 465 SER B 130 REMARK 465 THR B 131 REMARK 465 SER B 132 REMARK 465 GLY B 133 REMARK 465 ASP B 217 REMARK 465 LYS B 218 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER B 127 OG REMARK 470 THR B 135 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 38 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 CYS B 92 CA - CB - SG ANGL. DEV. = 7.7 DEGREES REMARK 500 PRO B 126 C - N - CA ANGL. DEV. = 21.7 DEGREES REMARK 500 PRO B 126 C - N - CD ANGL. DEV. = -19.3 DEGREES REMARK 500 PRO B 126 N - CA - C ANGL. DEV. = 19.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 30 -124.43 55.47 REMARK 500 ALA A 51 -40.30 67.70 REMARK 500 ALA A 84 -164.18 -178.00 REMARK 500 ASN A 138 71.80 41.99 REMARK 500 PRO A 141 -178.59 -68.95 REMARK 500 LYS A 169 -62.75 -93.04 REMARK 500 THR B 15 -16.89 79.85 REMARK 500 ALA B 100M 165.96 168.41 REMARK 500 PRO B 126 162.57 33.77 REMARK 500 SER B 156 26.96 49.07 REMARK 500 THR B 160 -34.31 -130.58 REMARK 500 SER B 186 -1.22 -51.85 REMARK 500 LYS B 214 -173.57 -48.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3D0L RELATED DB: PDB REMARK 900 RELATED ID: 2P8M RELATED DB: PDB REMARK 900 RELATED ID: 3IDI RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ REMARK 900 RELATED ID: 3IDG RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD REMARK 900 RELATED ID: 3IDM RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG REMARK 900 ELD(NRG)WAS REMARK 900 RELATED ID: 3IDN RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG REMARK 900 ELD(PAF)WAS DBREF 3IDJ A 1 214 PDB 3IDJ 3IDJ 1 214 DBREF 3IDJ B 1 218 PDB 3IDJ 3IDJ 1 218 DBREF 3IDJ C 1 7 PDB 3IDJ 3IDJ 1 7 SEQRES 1 A 214 ALA LEU GLN LEU THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 A 214 SER VAL GLY ASP ARG ILE THR ILE THR CYS ARG ALA SER SEQRES 3 A 214 GLN GLY VAL THR SER ALA LEU ALA TRP TYR ARG GLN LYS SEQRES 4 A 214 PRO GLY SER PRO PRO GLN LEU LEU ILE TYR ASP ALA SER SEQRES 5 A 214 SER LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 A 214 GLY SER GLY THR GLU PHE THR LEU THR ILE SER THR LEU SEQRES 7 A 214 ARG PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN LEU SEQRES 8 A 214 HIS PHE TYR PRO HIS THR PHE GLY GLY GLY THR ARG VAL SEQRES 9 A 214 ASP VAL ARG ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 A 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 A 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 A 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 A 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 A 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 A 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR GLU CYS GLU SEQRES 16 A 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 A 214 PHE ASN ARG GLY GLU CYS SEQRES 1 B 237 ARG ILE THR LEU LYS GLU SER GLY PRO PRO LEU VAL LYS SEQRES 2 B 237 PRO THR GLN THR LEU THR LEU THR CYS SER PHE SER GLY SEQRES 3 B 237 PHE SER LEU SER ASP PHE GLY VAL GLY VAL GLY TRP ILE SEQRES 4 B 237 ARG GLN PRO PRO GLY LYS ALA LEU GLU TRP LEU ALA ILE SEQRES 5 B 237 ILE TYR SER ASP ASP ASP LYS ARG TYR SER PRO SER LEU SEQRES 6 B 237 ASN THR ARG LEU THR ILE THR LYS ASP THR SER LYS ASN SEQRES 7 B 237 GLN VAL VAL LEU VAL MET THR ARG VAL SER PRO VAL ASP SEQRES 8 B 237 THR ALA THR TYR PHE CYS ALA HIS ARG ARG GLY PRO THR SEQRES 9 B 237 THR LEU PHE GLY VAL PRO ILE ALA ARG GLY PRO VAL ASN SEQRES 10 B 237 ALA MET ASP VAL TRP GLY GLN GLY ILE THR VAL THR ILE SEQRES 11 B 237 SER SER THR SER THR LYS GLY PRO SER VAL PHE PRO LEU SEQRES 12 B 237 ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA SEQRES 13 B 237 LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL SEQRES 14 B 237 THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL SEQRES 15 B 237 HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SEQRES 16 B 237 SER LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU SEQRES 17 B 237 GLY THR GLN THR TYR THR CYS ASN VAL ASN HIS LYS PRO SEQRES 18 B 237 SER ASN THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SER SEQRES 19 B 237 CYS ASP LYS SEQRES 1 C 7 GLU LEU ASP ORN TRP ALA SER MODRES 3IDJ ORN C 4 ALA ORNITHINE HET ORN C 4 8 HETNAM ORN L-ORNITHINE FORMUL 3 ORN C5 H12 N2 O2 FORMUL 4 HOH *210(H2 O) HELIX 1 1 ARG A 79 PHE A 83 5 5 HELIX 2 2 SER A 121 LYS A 126 1 6 HELIX 3 3 LYS A 183 LYS A 188 1 6 HELIX 4 4 LEU B 63 THR B 65 5 3 HELIX 5 5 SER B 83 THR B 87 5 5 HELIX 6 6 ARG B 100H ASN B 100L 5 5 HELIX 7 7 SER B 156 ALA B 158 5 3 HELIX 8 8 SER B 187 THR B 191 5 5 HELIX 9 9 LYS B 201 ASN B 204 5 4 SHEET 1 A 4 LEU A 4 SER A 7 0 SHEET 2 A 4 ILE A 19 ALA A 25 -1 O THR A 22 N SER A 7 SHEET 3 A 4 GLU A 70 ILE A 75 -1 O PHE A 71 N CYS A 23 SHEET 4 A 4 PHE A 62 SER A 67 -1 N SER A 63 O THR A 74 SHEET 1 B 6 SER A 10 ALA A 13 0 SHEET 2 B 6 THR A 102 VAL A 106 1 O ARG A 103 N LEU A 11 SHEET 3 B 6 ALA A 84 GLN A 90 -1 N ALA A 84 O VAL A 104 SHEET 4 B 6 LEU A 33 GLN A 38 -1 N ALA A 34 O GLN A 89 SHEET 5 B 6 GLN A 45 TYR A 49 -1 O LEU A 47 N TRP A 35 SHEET 6 B 6 SER A 53 LEU A 54 -1 O SER A 53 N TYR A 49 SHEET 1 C 4 SER A 10 ALA A 13 0 SHEET 2 C 4 THR A 102 VAL A 106 1 O ARG A 103 N LEU A 11 SHEET 3 C 4 ALA A 84 GLN A 90 -1 N ALA A 84 O VAL A 104 SHEET 4 C 4 THR A 97 PHE A 98 -1 O THR A 97 N GLN A 90 SHEET 1 D 4 SER A 114 PHE A 118 0 SHEET 2 D 4 THR A 129 PHE A 139 -1 O VAL A 133 N PHE A 118 SHEET 3 D 4 TYR A 173 SER A 182 -1 O LEU A 179 N VAL A 132 SHEET 4 D 4 SER A 159 VAL A 163 -1 N GLN A 160 O THR A 178 SHEET 1 E 4 ALA A 153 LEU A 154 0 SHEET 2 E 4 LYS A 145 VAL A 150 -1 N VAL A 150 O ALA A 153 SHEET 3 E 4 VAL A 191 THR A 197 -1 O GLU A 193 N LYS A 149 SHEET 4 E 4 VAL A 205 ASN A 210 -1 O LYS A 207 N CYS A 194 SHEET 1 F 4 THR B 3 SER B 7 0 SHEET 2 F 4 LEU B 18 SER B 25 -1 O SER B 23 N LYS B 5 SHEET 3 F 4 GLN B 77 MET B 82 -1 O MET B 82 N LEU B 18 SHEET 4 F 4 LEU B 67 ASP B 72 -1 N ASP B 72 O GLN B 77 SHEET 1 G 6 LEU B 11 VAL B 12 0 SHEET 2 G 6 ILE B 107 ILE B 111 1 O THR B 110 N VAL B 12 SHEET 3 G 6 ALA B 88 ARG B 95 -1 N ALA B 88 O VAL B 109 SHEET 4 G 6 GLY B 35 GLN B 39 -1 N ILE B 37 O PHE B 91 SHEET 5 G 6 GLU B 46 TYR B 52 -1 O LEU B 48 N TRP B 36 SHEET 6 G 6 LYS B 57 TYR B 59 -1 O ARG B 58 N ILE B 50 SHEET 1 H 4 LEU B 11 VAL B 12 0 SHEET 2 H 4 ILE B 107 ILE B 111 1 O THR B 110 N VAL B 12 SHEET 3 H 4 ALA B 88 ARG B 95 -1 N ALA B 88 O VAL B 109 SHEET 4 H 4 VAL B 102 TRP B 103 -1 O VAL B 102 N HIS B 94 SHEET 1 I 2 THR B 99 LEU B 100A 0 SHEET 2 I 2 VAL B 100D ALA B 100G-1 O ILE B 100F N THR B 99 SHEET 1 J 4 SER B 120 LEU B 124 0 SHEET 2 J 4 THR B 135 TYR B 145 -1 O LEU B 141 N PHE B 122 SHEET 3 J 4 TYR B 176 PRO B 185 -1 O LEU B 178 N VAL B 142 SHEET 4 J 4 VAL B 163 THR B 165 -1 N HIS B 164 O VAL B 181 SHEET 1 K 4 SER B 120 LEU B 124 0 SHEET 2 K 4 THR B 135 TYR B 145 -1 O LEU B 141 N PHE B 122 SHEET 3 K 4 TYR B 176 PRO B 185 -1 O LEU B 178 N VAL B 142 SHEET 4 K 4 VAL B 169 LEU B 170 -1 N VAL B 169 O SER B 177 SHEET 1 L 3 THR B 151 TRP B 154 0 SHEET 2 L 3 TYR B 194 HIS B 200 -1 O ASN B 197 N SER B 153 SHEET 3 L 3 THR B 205 VAL B 211 -1 O VAL B 211 N TYR B 194 SSBOND 1 CYS A 23 CYS A 88 1555 1555 2.05 SSBOND 2 CYS A 134 CYS A 194 1555 1555 2.02 SSBOND 3 CYS B 22 CYS B 92 1555 1555 2.06 SSBOND 4 CYS B 140 CYS B 196 1555 1555 2.03 LINK C ASP C 3 N ORN C 4 1555 1555 1.33 LINK C ORN C 4 N TRP C 5 1555 1555 1.33 CISPEP 1 SER A 7 PRO A 8 0 -1.65 CISPEP 2 TYR A 94 PRO A 95 0 -0.40 CISPEP 3 TYR A 140 PRO A 141 0 0.27 CISPEP 4 ALA B 125 PRO B 126 0 1.78 CISPEP 5 PHE B 146 PRO B 147 0 -1.50 CISPEP 6 GLU B 148 PRO B 149 0 0.13 CRYST1 58.400 64.900 175.600 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017123 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015408 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005695 0.00000